Feasibility of a Mechanical Power-Guided Lung Protective Ventilation (VentCoach) in Acute Hypoxemic and/or Hypercapnic Respiratory Failure

Overview

About this study

The purpose of this study is to assess the feasibility of implementation of, and adherence to VentCoach protocol in critically ill patients intubated for acute hypoxemic and/or hypercapnic respiratory failure. We hypothesize that, when compared to standard of care, VentCoach is feasible, safe, and easy to implement]

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with acute hypoxemic and/or hypercapnic respiratory failure.
  • Patients requiring intubation and mechanical ventilation for more than 24 hours.
  • VentCoach protocol is specific to volume controlled continuous mandatory ventilation (S-CMV).
  • Patient who are admitted to RMH 10-3/10-4 and MB 6BGF ICUs.
  • Age greater than or equal to 18 years.
  • Patient’s legal representative should be able to provide informed consent to the study. Any participant speaking any language will be offered participation.

Exclusion Criteria:

  • Intubation and mechanical ventilation for airway protection in the setting of procedures/surgeries; e.g. interventional radiology, surgery, or endoscopy.
  • Intubation and mechanical ventilation due to drug overdose with expected extubation of less than 24 hours.
  • Intubation and mechanical ventilation in the setting of cardiac arrest of primary cardiac etiology.
  • Intubation and mechanical ventilation for a primary neurological etiology; e.g. increased intracranial pressure, tumor mass effect, ischemic/hemorrhagic stroke, status epilepticus, etc.
  • Mechanical ventilation to be guided by esophageal balloon.
  • Subject deprived of freedom, minor, subject under a legal protective measure.
  • Change in end-of-life decision anticipated after enrollment (or estimated 6-month mortality rate of greater than 50%).

Note: Prone positioning is not a contraindication for participation.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 5/22/23. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Gustavo Cortes Puentes, M.D.

Open for enrollment

Contact information:

Brandon Clapp

(507) 284-2122

Clapp.Brandon@mayo.edu

More information

Publications

Publications are currently not available